Bio ProtocolBIO#286
Bio Protocol price chart
Technical indicators Calculated from daily closes
Derivatives (Perpetual)
About Bio Protocol
Bio Protocol (BIO) trades at $0.0300 on Binance with a 24-hour volume of $30.42M. With a market capitalization of $64.72M, Bio Protocol currently ranks #286 among cryptocurrencies. Its all-time high stands at $0.8890.
Frequently asked questions
What is Bio Protocol?
Bio Protocol (BIO) is a cryptocurrency tracked on the Binance exchange. It currently trades at $0.0300 with a 24-hour volume of $30.42M.
What is the current Bio Protocol price?
The current price of Bio Protocol is $0.0300 USD on Binance, updated every second via live data feeds.
How much is 1 BIO in USD?
As of the most recent update, 1 BIO = $0.0300 USD. The price may have changed by the time you read this — refresh to see the latest tick.
What is the 24h trading volume of Bio Protocol?
Bio Protocol has a 24-hour trading volume of $30.42M USD on the BIOUSDT pair.
Where can I trade Bio Protocol?
Bio Protocol is available on Binance under the BIOUSDT trading pair. NowPrice tracks the live price but does not facilitate trading.
What is the all-time high of Bio Protocol?
The all-time high of Bio Protocol (BIO) was $0.8890 on Jan 3, 2025. The current price is -96.6% from the ATH.
What is the market cap of Bio Protocol?
The market cap of Bio Protocol is $64.72M based on a circulating supply of 2.15B BIO. The fully-diluted valuation (FDV) is $100.18M.
Latest news
See all →
Bitcoin Tests $59K as ETFs Shed $692M, Options Expiry Looms
Bitcoin fell to around $59,400 as spot ETFs saw $691 million in outflows, the most since May, ahead of a $10.6 billion options expiry on Friday.
Australian Regulator Extends Crypto No-Action Period to Sept 30
Australia's financial regulator ASIC extended its no-action position for digital asset businesses until September 30, providing temporary relief as firms work toward licensing compliance.
Bitcoin beats Strategy as crypto ends first half in the red
Bitcoin's 32% decline in the first half of 2026 still outperformed Strategy's 43% drop, highlighting investor preference for assets tied to economic activity over narrative-driven plays.